The Shilin Newsletter provides an electronic weekly update of China's drug regulations and policies. The letters are archived, indexed, and hyperlinked via keywords. The service of Shilin Newsletter began in January 2026.

The Shilin Newsletter is based on Shilin, a daily updated integrated knowledge database of drug regulations and policies, as well as good practices of China, the United States, Europe, ICH, WHO and PIC/S. The Shilin content is hyperlinked in a Wikipedia style. Shilin currently serves over 170 organizations, including the state and provincial regulators, domestic and multinational drug companies in China. The service of Shilin began in 2013.

Contact Information

Phone: +86 10-6254-2532, 9am to 5pm, Monday to Friday (UTC+8)

Email: newsletter@shilinx.com

Address:

Beijing Shangzhihegui Science & Technology Ltd

Zhongyuan Science & Technology Building

Chaoyang District, Beijing, China

All Rights Reserved: sino-drug-regulation.com